Causal therapy of prion and Parkinson's disease with novel inhibitors of 
protein aggregation.

Kretzschmar, H.; Wagner, J.; Ryazanov, S.; Leonov, A.; Levin, J.; Shi, S.; Prix, C.; Groschup, M.; Griesinger, C.; Giese, A.

Item

ITEM ACTIONSEXPORT

Add to Basket

Please note that a newer version of this item is available:
https://pure.mpg.de/pubman/item/item_983615_5

DetailsSummary

Released

Conference Paper

Causal therapy of prion and Parkinson's disease with novel inhibitors of protein aggregation.

MPS-Authors

/persons/resource/persons45923

Ryazanov, S.
Department of NMR Based Structural Biology, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons15438

Leonov, A.
Department of NMR Based Structural Biology, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons15147

Griesinger, C.
Department of NMR Based Structural Biology, MPI for biophysical chemistry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Kretzschmar, H., Wagner, J., Ryazanov, S., Leonov, A., Levin, J., Shi, S., et al. (2011). Causal therapy of prion and Parkinson's disease with novel inhibitors of protein aggregation. Journal of Neuropathology and Experimental Neurology, 70(6), 505-505.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0011-F3B2-F

Abstract

There is no abstract available